Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High density lipoprotein measurement
|
1440 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.800 | 1.000 | 11 | 2007 | 2019 | |||||
Serum total cholesterol measurement
|
1243 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.800 | 1.000 | 3 | 2012 | 2019 | |||||
Coronary Artery Disease
|
1577 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.710 | 1.000 | 2 | 2013 | 2018 | |||||
Serum HDL cholesterol measurement
|
679 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.700 | 1.000 | 5 | 2008 | 2013 | |||||
Triglycerides measurement
|
1418 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.700 | 1.000 | 2 | 2007 | 2009 | |||||
Coronary heart disease
|
1178 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Lipids measurement
|
53 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||
Pseudocholinesterase Measurement
|
568 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Serum albumin measurement
|
3282 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Metabolic Syndrome X
|
591 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.020 | 1.000 | 2 | 2017 | 2019 | |||||
Cardiovascular Diseases
|
711 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Coronary Arteriosclerosis
|
440 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Diabetic Nephropathy
|
238 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Dyslipidemias
|
184 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Hypertensive disease
|
1085 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Myocardial Infarction
|
680 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Venous Thromboembolism
|
408 | 0.790 | 0.240 | 16 | 56961324 | upstream gene variant | C/A;G | snv | 0.51; 5.7E-06 | 0.010 | 1.000 | 1 | 2009 | 2009 |